Cargando…

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

OBJECTIVES: To explore the influence of age on treatment responses to atomoxetine and to assess the relationship between core symptoms of attention deficit/hyperactivity disorder (ADHD) and health-related quality of life (HR-QoL) outcomes. DATA SOURCES: Data from five similar clinical trials of atom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wehmeier, Peter M, Schacht, Alexander, Escobar, Rodrigo, Savill, Nicola, Harpin, Val
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012018/ https://www.ncbi.nlm.nih.gov/pubmed/21134277 http://dx.doi.org/10.1186/1753-2000-4-30

Ejemplares similares

Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians
por: Bushe, Chris J., et al.
Publicado: (2011)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012)

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
por: Price, Maxwell Z., et al.
Publicado: (2023)

Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials
por: Bushe, Chris J, et al.
Publicado: (2013)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Real‐World Dosing Patterns of Atomoxetine in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Kabul, Samaneh, et al.
Publicado: (2015)

Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder
por: Zhang, Ying, et al.
Publicado: (2021)

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder
por: Nagai, Tsutomu, et al.
Publicado: (2022)

Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings
por: Dittmann, Ralf W., et al.
Publicado: (2009)

Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials
por: Schacht, Alexander, et al.
Publicado: (2011)

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for Attention-Deficit/Hyperactivity Disorder (ADHD): Findings from two 24-week, open-label studies
por: Wehmeier, Peter M, et al.
Publicado: (2009)

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022)

Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder
por: Garg, Jasmin, et al.
Publicado: (2015)

Atomoxetine Induced Hypomania in a Patient with Bipolar Disorder and Adult Attention Deficit Hyperactivity Disorder
por: Kumar, Vijaya, et al.
Publicado: (2017)

Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
por: Kim, Jae Heon, et al.
Publicado: (2023)

Efficacy of atomoxetine in adult attention-Deficit/Hyperactivity Disorder: a drug-placebo response curve analysis
por: Faraone, Stephen V, et al.
Publicado: (2005)

A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder
por: Upadhyaya, Himanshu P., et al.
Publicado: (2013)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention‐Deficit/Hyperactivity Disorder
por: Clemow, David B., et al.
Publicado: (2016)

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder
por: Cao, Pengfei, et al.
Publicado: (2018)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009)

Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis
por: Montoya, Alonso, et al.
Publicado: (2013)

Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder
por: Hazell, Philip, et al.
Publicado: (2009)

Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)
por: Wehmeier, Peter M, et al.
Publicado: (2008)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
por: Hanwella, Raveen, et al.
Publicado: (2011)

Effects of Atomoxetine on Height and Weight in Korean Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review
por: Kweon, Kukju, et al.
Publicado: (2018)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
por: Carlson, Gabrielle A, et al.
Publicado: (2007)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities
por: Clemow, David B, et al.
Publicado: (2017)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
por: Nakanishi, Yoko, et al.
Publicado: (2017)

Clinical and Neuropsychological Factors Associated with Treatment Response and Adverse Events of Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder
por: Park, Kee Jeong, et al.
Publicado: (2019)

A case report: ‘happy heart’ syndrome in a patient treated with atomoxetine for attention deficit hyperactivity disorder
por: Athanassopoulos, Petros, et al.
Publicado: (2019)

Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in Swedish children and adolescents
por: Svanborg, Pär, et al.
Publicado: (2009)

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
por: Dickson, Ruth A, et al.
Publicado: (2011)

Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis
por: Rezaei, Golandam, et al.
Publicado: (2016)

Successful Treatment with Atomoxetine of an Adolescent Boy with Attention Deficit/Hyperactivity Disorder, Extreme Obesity, and Reduced Melanocortin 4 Receptor Function
por: Pott, Wilfried, et al.
Publicado: (2013)

Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine
por: Upadhyaya, Himanshu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_75h71l13icsa0huisu9stl28fn